Background. There is evidence of brain recovery on brain magnetic resonance imaging (MRI) early postliver transplant (LT), but the longer-term impact is unclear. The aim of this study was to determine the change in brain MRI parameters, cognition, and health-related quality of life (HRQOL) between 6 and 12 months post-LT. Methods. Listed cirrhotics underwent cognitive, HRQOL and brain MRI pre-LT, 6 months (post-LT1), and 1-year (post-LT2) post-LT. Assessment of MRI changes between visits was performed for ammonia-associated metabolite changes using magnetic resonance spectroscopy, white matter changes using tract-based spatial statistics analysis on diffusion tensor imaging data and grey matter changes using voxel-based morphometry analysis on 3D high resolution T1-weighted images. Results. Forty-five patients were included, of which 23 were tested at all visits. Cognitive and HRQOL scores improved between all visits compared with pre-LT values. This trend continued on magnetic resonance spectroscopy with reduced glutamine + glutamate and higher myoinositol, choline between pre-LT/ post-LT1 but lower degrees of improvement between post-LT1/post-LT2. On diffusion tensor imaging, mean diffusivity, linear diffusivity and mode of anisotropy continued to increase in the posterior internal capsule at both post-LT visits. On voxel-based morphometry, a continued increase was seen in basal ganglia grey matter between both post-LT visits was seen. Conclusions. HRQOL and cognition continue to improve compared with pre-LT values up to 1 year post-LT, although the rate of improvement slows down after 6 months. Grey matter increase is steady over time at 1 year although changes in ammonia-related metabolites and white matter integrity improve at a slower pace at 1 year post-LT.
H epatic encephalopathy (HE) is a neuropsychiatric condition occurring in patients with liver failure. It manifests as deficits in motor function, coordination, psychomotor function, sleep-waking cycle, and impaired thought process and cognition. Although the pathological mechanism of HE remains unclear, there is growing evidence that hyperammonemia and neuroinflammation may act synergistically to cause brain edema and neurotransmission disturbances leading to the neurological alterations in HE. 1 Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) are noninvasive techniques that have been used for investigating brain biomarkers for HE. 2 MRS provides information about the neurometabolic status. 3 High-resolution T1-weighted images and diffusion tensor imaging (DTI) along with advanced analysis techniques, such as voxel-based morphometry (VBM) and tract-based spatial statistics (TBSS), have been used to study the localized and global grey and white matter damage in cirrhosis respectively. [4] [5] [6] DTI is based on quantitative assessment of the mobility of water molecules. It has been used to study the microstructural integrity of axon and brain edema in cirrhotic patients. [7] [8] [9] [10] [11] HE is presumed to be largely reversed after successful liver transplant (LT). 3 However, there are variable results regarding cognitive changes long-term post-LT. 12 Although some studies have determined a continued improvement in cognition and daily function, others have shown a staggered course in those with pre-LT HE. 13, 14 Fewer studies have evaluated the role of multimodal brain MRI changes over a longer period and longitudinal analyses of these MRI changes have also provided conflicting results. [15] [16] [17] Cordoba et al reported a progressive improvement in magnetization-transfer ratio (marker for brain edema) and MRS between pre-LT, 1 month post-LT, and 1 year post-LT without continued improvement in cognition at 1 year post-LT. Garcia-Martinez et al 15 performed neuropsychological assessments before and 6 to 12 months after LT. They also performed MRS and total brain volume assessment only after-LT to show a relationship of previous HE with post LT outcome. Lin et al 18 showed improved extracellular cerebral edema and cognitive tests 6 to 12 months after transplant. They also showed a possible advancement of white matter demyelination in the temporal lobe. Our previous study showed that at 6 months post-LT, there is a significant improvement in cognitive performance and health-related quality of life (HRQOL). This was accompanied by a significant improvement in white matter integrity and astrocytic consequences of hyperammonemia on multimodal MRI. 19 The follow-up of that study, however, was limited to 6 months and did not include VBM. In this study, we evaluated cognitive, HRQOL tests and brain metrics, including brain volumes using VBM 1 year post-LT.
We hypothesized that there would be continued improvement in MRI metrics, cognition, and HRQOL when comparing 1 year post-LT with 6 months post-LT, whereas remaining better compared with the pre-LT baseline.
MATERIALS AND METHODS
We prospectively included patients with cirrhosis listed for deceased solitary LT at the Virginia Commonwealth University (VCU) Medical Center from June 2011 to June 2015. Patients who were able to give informed consent who were between 21 and 65 years of age, able to tolerate multimodal brain MRI and were followed up over 1 year post-LT were included. We excluded those with severe depression (Beck Depression Inventory >20) 20 ; who were not able to give informed consent; inability to tolerate or contraindications to brain MRI; dropout over 1 year post-LT; previous transplant, human immunodeficiency virus infection, or those who are listed under priority 1 status.
At the pretransplant visit, the subjects were given the mini mental status examination and were only allowed to proceed if it was 25 or higher. After this, we performed HRQOL assessment using the Sickness Impact Profile (SIP) 21 which has a total of 12 domains, 2 dimensions and total score. Scores from Psychosocial and Physical dimensions and the total scores were calculated. A high total SIP score suggests poor HRQOL and vice versa. Cognitive testing was administered by a highly experienced and trained nurse (M.B.W.) using 5 paper-pencil tests: The Psychometric Hepatic Encephalopathy Score (PHES) consists of 5 separate tests; the number connection test-A and number connection test-B, the digit symbol test, the serial dotting test, and the line drawing test. These tests evaluate attention, visuospatial perception, visuospatial construction, psychomotor speed, and motor accuracy, that is, domains that have been shown to be affected by HE. Compared with a healthy control population, the number of standard deviations impaired are calculated for each test and assigned points. An aggregate less than −4 points is considered impaired according to the local ageand education-adjusted norms. PHES is widely considered as the current "gold standard" in diagnosing cognitive impairments in cirrhosis at an early stage. 22 Additionally, a block design test was administered as a measure of visuospatial motor functioning. 23 All subjects then underwent multimodal brain MRI (details below). Subjects were then followed up until liver transplantation and up to 12 months beyond that. The transplant surgery details, immunosuppression regimen, hospitalizations, rejection episodes, and continued need for organ support, such as dialysis, were recorded. The first posttransplant visit was performed at 6 (±3) months for patients who were alive and willing and had not undergone a second transplant or were listed for another transplant (including renal transplant); and the second one was performed at 12 (±4) months. At both post-LT visits, all procedures performed at the baseline visit, including brain MRI, were repeated.
MRI Acquisition
All images during the pre-LT, post-LT1, and post-LT2 sessions were acquired on a 1.5 T Siemens Avanto (Erlangen, Germany) scanner using a quadrature birdcage RF head coil (Supplementary data, SDC, http://links.lww.com/TP/B502).
MR Spectroscopy Analysis
The choline (Cho), creatine (Cr), myoinositol (mI), and glutamate + glutamine (Glx) complex peak areas were computed using a quantitative assessment of the metabolite concentration by means of LCModel software. 24, 25 These metabolites were chosen because of previous research showing cirrhosisrelated changes in these metabolites 2 Concentration ratios were computed with respect to Cr concentration. LCModel uses a basis set of reference in vitro MR spectra for all major metabolites to deduce absolute concentrations of corresponding compounds from in vivo MR brain spectra. The model corrects for residual eddy current and RF coil loading effects and allows for an estimate and subtraction of the spectral baseline nonlinearity which is normally present at the short TE used in this study. 24, 25 
VBM
Structural data was analyzed with FMRIB Software Library (FSL)-VBM, 26 an optimized VBM protocol 27 carried out with FSL tools. 28 First, structural images were brain-extracted and grey matter-segmented before being registered to the Montreal Neurological Institute 152 standard space using nonlinear registration. The resulting images were averaged and flipped along the x-axis to create a left-right symmetric, study-specific grey matter template. Second, all native grey matter images were nonlinearly registered to this study-specific template and "modulated" to correct for local expansion (or contraction) because of the nonlinear component of the spatial transformation. The modulated grey matter images were then smoothed with an isotropic Gaussian kernel with a sigma of 2 mm. Finally, voxelwise GLM was applied using permutation-based nonparametric testing, 29 correcting for multiple comparisons across space.
DTI Analysis
Diffusion-weighted images were processed using tools in FSL (FMRIB Software Library version 5, www.fmrib.ox.ac. uk/fsl [30] [31] [32] ). After visual inspection for signal dropout, artifacts, and head motion, diffusion images were corrected for eddy current-related distortions and simple head motion using affine registration to a reference volume. Diffusion tensor model was fitted voxelwise to generate maps of fractional anisotropy (FA), mean diffusivity (MD), and linear diffusivity (LD), radial diffusivity (RD), and mode of anisotropy (MO). Voxelwise statistical analysis of the FA data was carried out using tract-based spatial statistics (TBSS 33 ), part of FSL 28 (Supplementary data, SDC, http://links.lww.com/TP/B502).
Statistical Analysis
All statistical analyses were performed using the SPSS (version 22, SPSS Inc., Chicago, IL) with appropriate tests. To assess the impact of time on the measures, a mixed linear model (MLM) was used to fit a repeated-measures analysis of variance model. MLM is superior to the repeated-measures analysis of variance model in that all observations available are utilized for analysis and this all subjects with data are utilized, not just completers. The MLM fit had one within subject factor (time: pre-LT, post-LT1, and post-LT2) and an unstructured variance-covariance matrix was used to model the within subject variance. If there was a significant time effect, the post hoc comparisons of the timepoints were performed utilizing a Bonferroni correct to adjust for multiple comparisons. We also compared the completers (all 3 visits vs noncompleters who had only 2 visits completed) with respect to HRQOL, cognitive testing, and MRS parameters. Voxelwise analyses, such as TBSS and VBM, require the number of subjects to be same at all timepoints to avoid introducing registration bias; therefore, MLM could not be performed for these parameters. HRQOL, cognitive testing, MRS, diffusion indices (FA, MD, LD, RD, MO), and grey matter density (VBM) were also compared before and after transplant by the 2-tailed paired t-test between pre-LT, post-LT1 and post-LT2 sessions, that is, pre-LT versus post-LT1, post-LT1 versus post-LT2, and pre-LT versus post-LT2 in the groups who had completed all 3 visits. Multiple comparison correction was done using Holms-Bonferroni method for all testing (except for voxelwise analyses) at a significance level α = 0.05. Voxelwise comparisons in TBSS and VBM were performed using nonparametric permutation testing using 5000 permutations test and the resultant maps were corrected for family-wise error (<0.05) followed by threshold-free cluster enhancement method.
The study protocol was approved by the VCU and Richmond VA Institutional Review Boards. No changes were seen between post-LT1 and post-LT2.A significant improvement in most cognitive tests and laboratory values was seen in all patients after transplant. A high score on block design and digit symbol test indicates good performance; the reverse is true for other cognitive tests. Similar changes were found on repeated-measures analysis.
RESULTS

Patients
Forty-five patients with a median listing age of 54 years with median Model for End-Stage Liver Disease (MELD) score of 21 were included, who had been followed up from pre-LT to post-LT status. Of these, 11 only had 1 post-LT MRI at 6 months, 5 were lost to follow-up, and 6 had technical issues in brain MRI evaluation at 1 year. All patients were included in the MLM analysis for cognitive function, HRQOL and MR spectroscopy ( Table S1 , SDC, http:// links.lww.com/TP/B502). In addition, we studied the 23 patients with cirrhosis who had completed all 3 MRI sessions; pre-LT, post-LT1(6 ± 2 months), and post-LT2(12 ± 3 months). The median age was 56 years, median MELD was 26, and most were men (n = 16). Etiology of cirrhosis was hepatitis C virus (HCV) in 11 patients, alcohol + HCV in 5 patients, and nonalcoholic fatty liver disease in 7 patients. Eight patients were listed for hepatocellular cancer, 11 patients had previous overt HE (all on lactulose and rifaximin), and 9 patients had impaired PHES suggestive of covert HE pre-LT (Table 1) . When comparing the completer versus noncompleter sample, there were no significant differences in median PHES score pre-LT (completer, −4; noncompleter, −4; P = 0.4) or post-LT1 (completer, −1; noncompleter, 0; P = 0.5). There were no significant differences in pre-LT values of total SIP (completer, 21.60 ± 14.8 vs noncompleter, 22.6 ± 13. 
Peritransplant and Posttransplant Course
Patients underwent LT a median of 6 months (interquartile range [IQR], 2-10 months) after listing. There were no HE-related admissions during the interim period, but 6 were hospitalized because of ascites (n = 3) and infections (n = 3) after which they were reactivated on the list. The perioperative period for the twenty-three included subjects was uneventful, without early rejection, continuing organ failure or primary graft nonfunction, with a median hospital stay of 9 (IQR, 4-21 days) . The standard VCU immunosuppression regimen includes tapering steroids over a month with mycophenolate mofetil initiated perioperatively. Calcineurin inhibition in the form of tacrolimus is introduced at day 3 to achieve levels between 8 and 12 ng/mL in the first 3 months and between 5 and 10 ng/mL after that period, depending on the cirrhosis cause.
Of the 23 patients, 7 required interventions before post-LT1 (2 with rejection requiring steroids in all and ATG in one, 2 with biliary complications necessitating interventions and 2 with delirium requiring a switch from tacrolimus to cyclosporine). Between post-LT1 and post-LT2 visits, 2 patients required biliary interventions with cholangitis and 1 developed Clostridium difficile colitis. All these episodes were satisfactorily treated at least 2 months before the cognitive testing and MRI scans at both post-LT visits.
Regular tacrolimus trough levels were monitored throughout, and all patients were within the proscribed trough range (10.1 ± 3.7 ng/mL average tacrolimus level before post-LT1 and 7.3 ± 3.2 ng/mL before post-LT2 visits).
None of the HCV patients had sustained virological response pretransplant and did not receive any anti-HCV therapy before the posttransplant testing. No antipsychotic medications were initiated, and there was no evidence of impaired comprehension (Mini-mental status evaluation was >25), tremors, or focal neurological deficits at both post-LT visits. There was a significant improvement in laboratory, cognitive, and HRQOL between pre-LT and both post-LT visits using paired t tests for the completers and the MLM ( Table 2, and Table S1 , SDC, http://links.lww.com/TP/B502). 
HRQOL and Cognitive Testing
Total SIP and its components significantly decreased from pre-LT to post-LT1 session without further changes during the post-LT2 session (Table 2) . Similarly, there was significant increase in PHES scores from pre-LT to post-LT1. Both SIP and PHES scores did not change significantly between post-LT1 and post-LT2 ( Figure 1A, B) . When all patients were considered, this trend remained similar with total SIP and the 2 domains (Table S1 , SDC, http://links.lww.com/TP/B502).
MR Spectroscopy
There was a significant increase in Cho/Cr and mI/Cr and decrease in Glx/Cr in the post-LT1 session with no further improvement in the post-LT2 session in right parietal white matter, posterior gray matter, and anterior cingulate gyrus (Figure 2A-C) using the completer sample. Post-LT2 measures were significantly better than pre-LT. Using the MLM, this trend was again seen.
DTI
We found no significant differences in diffusion metrics between post-LT1 and post-LT2 sessions. Compared with pre-LT session, both post-LT1 and post-LT2 sessions showed a significant increase in LD and MO in the posterior limb of the internal capsule ( Figure 3 ) with concurrent increase in MD without any significant changes in FA or RD. Increase in LD was also observed in the splenium of the corpus callosum in post-LT1 and post-LT2 compared with pre-LT (Table 3) .
VBM
Six months after transplant (post-LT1), we found significant increase in grey matter volume in brain regions within the basal ganglia, anterior cingulate cortex, frontal and temporal gyri, and decrease in grey matter volume in the thalamic regions. The grey matter volume continued to increase in the basal ganglia alone 12 months (post-LT2) after transplant (Figure 4A-B; Tables 4 to 6) .
DISCUSSION
Several studies have demonstrated cognitive recovery after LT. 15, 16, 19, 33 However, the timeline of these improvements has been variable. In this study, we investigated the integrated trajectory of improvement in HRQOL, cognition, and brain metabolic and structural components over the course of a year post-LT, which is novel for this population. Although the analyses between pre-LT and 6 months have been published, we believe that this article adds significantly to our knowledge. Specifically, the novel information is related to (a) length of follow-up over 1 year, (b) use of VBM, and (c) use of voxelwise analysis of DTI instead of regions-ofinterest-based analysis used in the previous study. The 1-year timepoint is important because it gives clinicians a clearer picture as to what to expect cognitively and functionality-wise in patients. These patients at 1 year are more prone to post-LT metabolic sequelae and potential recurrence of diseases that caused the cirrhosis. Therefore, extending findings over time and noting improvement compared to the pre-LT baseline is an important and novel translational question. VBM is critical in determining volumetric changes, which indeed continued to change at all timepoints. The voxel-based analysis helps in localization and determining the shape of the diffusion tensor in greater detail compared to the regions of interest-based analysis. The potential mechanism by which hyperammonemia and neuroinflammation may cause neurodegenerative effects is as follows: Ammonia crosses the blood-brain barrier and is metabolized by astrocytes into glutamine, which is a precursor of glutamate and gamma-hydroxybutyric acid: the main excitatory and inhibitory neurotransmitters, respectively. 17 Increased astrocytic glutamine causes an influx of water leading to astrocytic swelling and brain edema. In chronic liver disease, the astrocyte compensates for excess glutamine by releasing other metabolites to the extracellular environment. The presence of ammonia, lactate and glutamate can activate the microglia, the macrophages of the brain, which then release a wide range of proinflammatory cytokines and chemokines.
1 Sustained release of cytokines and chemokines may compromise the blood-brain barrier which in turn may further expose the interstitial space to neurotoxins, such as ammonia and peripheral immune cells, ultimately leading to neurodegeneration. 3 Therefore, multimodal MRI techniques are well suited for studying these brain changes due to liver disease and evaluating the efficacy of treatments, such as liver transplantation.
Posttransplant, we saw an expected decrease in Glx and increase in mI and Cho in all 3 regions of interest studied, indicating a reversal of hyperammonemia-related changes in glutamine production and compensatory behavior of the other metabolites. These results suggest a decrease in low grade brain edema after transplant 16, 19, 34 that continues to evolve favorably between 6 months and 1 year post-LT. After LT, DTI analysis showed an increase in linear diffusivity and mode of anisotropy in the posterior limb of the internal capsule. This indicates a shift from diffusivity of water molecules from a planar direction to an increasingly linear direction, suggesting an increase in axonal integrity. A significant portion of the posterior limb of internal capsule contains the fibers of the corticospinal tract which contain axons originating from frontal and parietal areas and are involved in voluntary movement and sensory functions. 35 This recovery continued at 1 year after LT, which even though was not statistically significant, implies that this process evolves over time differently in different brain white-matter regions. This was accompanied by an LD increase in the splenium region of the corpus callosum may have been associated with improved interhemispheric information transfer in study subjects.
The novel VBM analysis revealed a reversal of grey matter volume changes post-LT that continued up to 1 year. Previous studies 5, 33 reported a significant decrease in grey matter density in cirrhosis, which was indicative of increasing atrophy and worse hepatic function, likely due to hyperammonemia. 15 Six months after transplant, our results indicate an increase in grey matter volume in basal ganglia, a group of subcortical nuclei responsible primarily for motor control and learning and because of its rich connections to both cortical and subcortical structures, ultimately impacts cognitive function, behavior, and emotions. 36, 37 Other brain regions associated with increased grey matter volume at 6 months posttransplant include the anterior cingulate cortex, involved in attention, 38 and emotional suffering 39, 40 ; temporal gyri, associated with language and memory; and frontal gyri involved in working memory and inhibitory control. 35 Thus, the multimodal brain imaging findings complement the cognitive improvement on tests that assess these domains. We also found a decrease in thalamic and hippocampal volumes after transplant. The increase in thalamus grey matter has been previously reported in cirrhosis patients. 5 Although the precise reasons for thalamic size change remains uncertain, studies suggest that increased thalamic volume is a compensatory response to a corresponding decrease in basal ganglia grey matter regions. A possible mechanism for this dynamic reflects a redistribution of cerebral blood flow from the cortices to the thalamus in cirrhotic patients. These blood flow changes facilitate increased glucose and ammonia metabolism in the thalamus, with a corresponding metabolism reduction in other cortical regions. The increased blood flow and metabolism in the thalamus might be associated with neuronal and/or glial hypertrophy or hyperplasia, resulting in increased volume. Given the rich connections between hippocampal and thalamic structures the larger hippocampal volumes seen pre-LT may reflect the same dynamic. Importantly, we found continued improvement in grey matter density until 1 year post LT in Regions with significant grey matter volume increase in post-LT2 compared with post-LT1 Familywise error rate, P < 0.05.
basal ganglia regions. This continued increase in basal ganglia density was associated with improvement in cognition and HRQOL, which despite not reaching significance compared with the 6-month mark, showed a continuous trajectory of improvement. Specifically, improvements in SIP values continued and most individual cognitive tests improved at the 1 year timepoint.
Overall our results suggest that post-LT cirrhosis patients evolve at different trajectories over time post-LT with most dramatic differences between pre-LT and 6 months and continued improvement thereafter with regard to their cognitive and HRQOL. This was found when all comers were analyzed and also using only the completer sample. This was complemented by specific structural and metabolic changes reflecting further recovery of function even after 6 months. In summary, patients at 1 year post-LT enjoyed better cognitive function, HRQOL, and, based on multimodal MRI brain imaging measures, improved cortical structure and function.
One of the limitations of the study was that patients who had an eventful post-LT course did not follow-up for repeat MRI sessions. Therefore, the interpretation of these results should be limited to patients whose course was stable. Another limitation of this study was our relatively small sample size. The choice of waiting 6 months for the first follow-up post-LT may be considered a limitation. At the 1-month follow-up, Cordoba et al 16 found that some metrics were either worse or at pre-LT levels, and they attributed this to neurological effects of surgery and postsurgical management and slower evolution of certain brain metrics and cognitive function relative to others. Therefore, while designing the study, we wanted to exclude the potentially confounding neurological effects of surgery and early postoperative complications and management on our results, while giving sufficient time for all domains to potentially evolve. Finally, due to our sample-size we could not separately evaluate the post-LT trajectory for patients with previous HE episodes, patients with pre-LT covert HE and patients based on etiology. Although previous studies have shown neurological differences between these sub-groups, the brain regions involved are similar with only magnitude of differences being variable. More importantly, hyperammonemia and neuroinflammation are still the factors driving the cognitive impairments which LT potentially addresses.
We conclude that the improvements seen in cognition, quality of life, brain metabolites, and brain structures at 6 months post-LT improve, but at a slower pace between 6 months and 12 months post-LT, and remain significantly better compared with the pre-LT baseline. These results provide insight to guide clinicians while counseling patients and caregivers regarding the stability of functional improvement after LT.
